We are live on ! Find out more
BRM

Boston Research & Management Portfolio holdings

AUM $421M
1-Year Est. Return 16.18%
This Fund
S&P 500
This Quarter Est. Return
+0.37%
1 Year Est. Return
+16.18%
3 Year Est. Return
+48.21%
5 Year Est. Return
+65.09%
10 Year Est. Return
+242.1%
AUM
$403M
AUM Growth
-$4.68M
Cap. Flow
-$2.76M
Cap. Flow %
-0.68%
Top 10 Hldgs %
28.94%
Holding
118
New
3
Increased
17
Reduced
54
Closed
2

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$3.56M
2
ADBE icon
Adobe
ADBE
+$1.61M
3
TSLA icon
Tesla
TSLA
+$422K
4
AFL icon
Aflac
AFL
+$199K
5
WEC icon
WEC Energy
WEC
+$194K

Top Sells

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$1.52M
2
IVV icon
iShares Core S&P 500 ETF
IVV
+$1.09M
3
QRVO icon
Qorvo
QRVO
+$877K
4
ABT icon
Abbott
ABT
+$388K
5
JPM icon
JPMorgan Chase
JPM
+$326K

Sector Composition

Rank Sector Weight
1 Technology 14.02%
2 Consumer Staples 11.95%
3 Healthcare 11.84%
4 Financials 10.61%
5 Industrials 10.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IVV icon
1
iShares Core S&P 500 ETF
IVV
$876B
$17.1M 4.25%
30,459
-1,839
-6% -$1.09M
MSFT icon
2
Microsoft
MSFT
$2.84T
$15.8M 3.91%
41,961
+89
+0.2% +$36.3K
AAPL icon
3
Apple
AAPL
$4.89T
$12.6M 3.12%
56,546
-519
-0.9% -$120K
WMT icon
4
Walmart Inc
WMT
$871B
$11.5M 2.86%
131,354
-2,548
-2% -$239K
MA icon
5
Mastercard
MA
$477B
$11.4M 2.83%
20,817
-520
-2% -$283K
ABBV icon
6
AbbVie
ABBV
$458B
$10.7M 2.65%
50,858
-1,278
-2% -$248K
BRK.B icon
7
Berkshire Hathaway Class B
BRK.B
$1.07T
$10.1M 2.52%
19,041
-575
-3% -$280K
TSCO icon
8
Tractor Supply
TSCO
$16.3B
$9.64M 2.39%
174,970
-4,130
-2% -$226K
CSCO icon
9
Cisco
CSCO
$450B
$9M 2.24%
145,883
-2,280
-2% -$140K
JPM icon
10
JPMorgan Chase
JPM
$939B
$8.74M 2.17%
35,630
-1,280
-3% -$326K
FAST icon
11
Fastenal
FAST
$54B
$8.27M 2.05%
213,354
-1,956
-0.9% -$73.3K
GOOGL icon
12
Alphabet (Google) Class A
GOOGL
$3.91T
$8.04M 2%
51,979
-151
-0.3% -$27.4K
ABT icon
13
Abbott
ABT
$180B
$7.87M 1.95%
59,316
-3,050
-5% -$388K
XYL icon
14
Xylem
XYL
$28.5B
$7.74M 1.92%
64,817
-345
-0.5% -$42.8K
IJR icon
15
iShares Core S&P Small-Cap ETF
IJR
$109B
$7.72M 1.92%
73,844
+79
+0.1% +$8.91K
MCD icon
16
McDonald's
MCD
$188B
$7.71M 1.91%
24,684
-362
-1% -$108K
PG icon
17
Procter & Gamble
PG
$343B
$7.51M 1.86%
44,072
-437
-1% -$73.2K
BNY
18
Bank of New York Mellon
BNY
$108B
$7.42M 1.84%
88,537
-3,073
-3% -$258K
LIN icon
19
Linde
LIN
$237B
$7.35M 1.83%
15,792
-223
-1% -$100K
GIS icon
20
General Mills
GIS
$19.2B
$6.57M 1.63%
109,806
+2,419
+2% +$145K
AMZN icon
21
Amazon
AMZN
$2.5T
$6.55M 1.63%
34,439
-525
-2% -$114K
XOM icon
22
ExxonMobil
XOM
$651B
$6.35M 1.58%
53,412
+708
+1% +$78.3K
SNA icon
23
Snap-on
SNA
$20.9B
$6.22M 1.54%
18,461
-330
-2% -$112K
CL icon
24
Colgate-Palmolive
CL
$72.6B
$5.9M 1.47%
62,981
-790
-1% -$70.7K
ACN icon
25
Accenture
ACN
$89.9B
$5.79M 1.44%
18,555
+16
+0.1% +$5.65K

Similar funds

Boston Research & Management's Q1 2025 Portfolio in Review

As of Q1 2025, Boston Research & Management held 118 positions worth $403M, down 1.1% from $407M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Trading was light in Q1 2025: portfolio turnover was 4.2%. Boston Research & Management opened 3 new positions and exited 2, leaving the 118-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Consumer Staples and Healthcare.

  • Boston Research & Management's largest Q1 2025 buy was Tesla: 1,265 shares worth $327K.
  • Boston Research & Management added most to NVIDIA in Q1 2025, an estimated $3.56M increase.
  • Boston Research & Management's biggest Q1 2025 reduction was iShares Core S&P 500 ETF, cutting an estimated $1.09M.
  • Boston Research & Management fully exited CVS Health in Q1 2025, selling an estimated $1.52M.
  • Boston Research & Management's ten largest holdings make up 29% of its $403M portfolio in Q1 2025.
  • Boston Research & Management opened 3 new positions and closed 2 in Q1 2025.
  • Boston Research & Management's portfolio value fell 1.1% quarter-over-quarter to $403M.

Based on Boston Research & Management's 13F filing for Q1 2025, filed 12 May 2025.